SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-14-020188
Filing Date
2014-01-24
Accepted
2014-01-24 14:22:30
Documents
1
Group Members
CLARUS VENTURES I MANAGEMENT, L.P. (CLARUS I MANAGEMENT)CLARUS VENTURES I, LLC (CLARUS I GPLLC)DENNIS HENNERKURT WHEELERMICHAEL STEINMETZNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D d663848dsc13da.htm SC 13D/A 41110
  Complete submission text file 0001193125-14-020188.txt   43034
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 650 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 650 SAN DIEGO CA 92130 (858) 259-1165
ZOGENIX, INC. (Subject) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85795 | Film No.: 14545519
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences I, L.P. (Filed by) CIK: 0001431445 (see all company filings)

IRS No.: 203855540 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A